PD-L1 expression in non-small cell lung cancer according to specimen type; a retrospective study of over 2,000 cases

被引：0
|
作者：
Elwin, F. [1 ]
Haragan, A. [1 ]
Gosney, J. [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
来源：
LUNG CANCER | 2020年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
131
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations
    Scheel, Andreas H.
    Ansen, Sascha
    Schultheis, Anne M.
    Scheffler, Matthias
    Fischer, Rieke N.
    Michels, Sebastian
    Hellmich, Martin
    George, Julie
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry
    Timens, Wim
    Perner, Sven
    von Bergwelt-Baildon, Michael
    Buettner, Reinhard
    Wolf, Juergen
    ONCOIMMUNOLOGY, 2016, 5 (05):
  • [22] Effect of neoadjuvant chemoimmunotherapy on PD-L1 expression in non-small cell lung cancer
    Stoykova, S.
    Chriqui, L.
    Berchtold, E. Abdelnour
    Peters, S.
    Perentes, J. Y.
    Berezowska, S.
    VIRCHOWS ARCHIV, 2024, 485 : S20 - S20
  • [23] TMB, genetic alterations and PD-L1 expression in non-small cell lung cancer
    Gureviciene, Giedre
    Matulione, Jurgita
    Poskiene, Lina
    Miliauskas, Skaidrius
    Zemaitis, Marius
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [24] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [25] Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations
    Gagne, Andreanne
    Wang, Emily
    Bastien, Nathalie
    Orain, Michele
    Desmeules, Patrice
    Page, Sylvain
    Trahan, Sylvain
    Couture, Christian
    Joubert, David
    Joubert, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2062 - 2070
  • [26] Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer
    Cho, Jong Ho
    Zhou, Wei
    Choi, Yoon-La
    Sun, Jong-Mu
    Choi, Hyejoo
    Kim, Tae-Eun
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Rutkowski, Mary Anne
    Kim, Jhingook
    CANCER RESEARCH AND TREATMENT, 2018, 50 (01): : 95 - 102
  • [27] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
  • [28] Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β
    Hirayama, Aiko
    Tanaka, Kentaro
    Tsutsumi, Hirono
    Nakanishi, Takayuki
    Yamashita, Sho
    Mizusaki, Shun
    Ishii, Yumiko
    Ota, Keiichi
    Yoneshima, Yasuto
    Iwama, Eiji
    Okamoto, Isamu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)
    Cao, Xiaobo
    Zhao, Yang
    Wang, Jing
    Dai, Bingbing
    Gentile, Emanuela
    Lin, Jing
    Pu, Xingxiang
    Ji, Lin
    Wu, Shuhong
    Meraz, Ismail
    Majidi, Mourad
    Roth, Jack A.
    ONCOTARGET, 2017, 8 (64) : 107621 - 107629
  • [30] PREDICTORS OF PD-L1 TESTING IN NON-SMALL CELL LUNG CANCER
    DiBonaventura, M.
    Meyers, A.
    Higginbottom, K.
    Morimoto, Y.
    Ilacqua, J.
    VALUE IN HEALTH, 2016, 19 (07) : A763 - A763
12345